Braze reports Q1 results today with short sellers sitting on their heaviest losses of the quarter, the stock having rocketed 17% in a single week to $25.45 while peers sold off.
Short interest is a central part of this story. At 14.2% of the free float — roughly 14 million shares — the positioning is genuinely elevated, and it has barely budged despite the squeeze. Bears added modestly over the past week, up almost 4%, even as the price surged. That stubbornness is notable: short sellers are not covering, which means the pain trade is still live heading into tonight's print. The lending market is not tight, however. Availability runs at around 620% of short interest — there are more than six shares available to borrow for every one currently shorted — and the cost to borrow is just 0.45%, near its lowest level in recent months. The borrow market is not amplifying pressure; any squeeze would have to come from the price itself.
Options positioning has turned more defensive just as the stock ripped higher. The put/call ratio climbed to 0.26, more than two standard deviations above its 20-day average of 0.19 — the most bearish options skew in months. That divergence is the key tension heading into earnings: the stock just had its best weekly gain since at least March, yet options traders are loading up on downside protection at the same time. Either they are hedging a position they don't want to lose after the rally, or they expect the print to disappoint and reverse the move.
The bull case rests on Braze's AI-driven cross-channel platform, improving free cash flow (FCF as a share of sales rose from 0.18 to 0.23 over the past six months), and strong forward EPS momentum — the 90-day estimate revision score ranks in the 73rd percentile. Analysts remain broadly constructive: the consensus mean target is $34.85, implying roughly 37% upside from current levels. BTIG reiterated its Buy and $30 target yesterday, the most recent call on the stock. Goldman Sachs and Citigroup both trimmed targets back in March after the prior earnings report — cutting to $40 and $46 respectively while maintaining Buy ratings — a pattern that signals continued confidence tempered by execution caution. The bear case is harder to dismiss: Braze has not turned a profit, competes directly against Adobe and Salesforce, and concentrates meaningful revenue exposure in B2C and e-commerce clients. The last earnings print in late March delivered a 14% one-day gain and a nearly 25% five-day rally, which explains the current positioning — the stock was already heavily shorted going into that report too, and the cover scramble amplified the move.
Institutional flows add another layer. Vanguard and Fidelity both took new or sharply increased positions as of March 31, while Mcg7 Capital trimmed by 925,000 shares. CEO William Magnuson and a cluster of other insiders sold shares on May 15 at $20.87 — well below the current price — typical of pre-planned sales, though the broad participation across the C-suite is worth noting. Today's print will test whether the March earnings momentum was a one-quarter event or the start of a durable re-acceleration in revenue growth that justifies the stock reclaiming ground closer to its analyst targets.
See the live data behind this article on ORTEX.
Open BRZE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
